302 related articles for article (PubMed ID: 28442586)
21. Does Stereotactic Radiosurgery Positively Impact the Local Control of Atypical Teratoid Rhabdoid Tumors?
Spina A; Gagliardi F; Boari N; Bailo M; Mortini P
World Neurosurg; 2017 Aug; 104():612-618. PubMed ID: 28461278
[TBL] [Abstract][Full Text] [Related]
22. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.
Torchia J; Golbourn B; Feng S; Ho KC; Sin-Chan P; Vasiljevic A; Norman JD; Guilhamon P; Garzia L; Agamez NR; Lu M; Chan TS; Picard D; de Antonellis P; Khuong-Quang DA; Planello AC; Zeller C; Barsyte-Lovejoy D; Lafay-Cousin L; Letourneau L; Bourgey M; Yu M; Gendoo DMA; Dzamba M; Barszczyk M; Medina T; Riemenschneider AN; Morrissy AS; Ra YS; Ramaswamy V; Remke M; Dunham CP; Yip S; Ng HK; Lu JQ; Mehta V; Albrecht S; Pimentel J; Chan JA; Somers GR; Faria CC; Roque L; Fouladi M; Hoffman LM; Moore AS; Wang Y; Choi SA; Hansford JR; Catchpoole D; Birks DK; Foreman NK; Strother D; Klekner A; Bognár L; Garami M; Hauser P; Hortobágyi T; Wilson B; Hukin J; Carret AS; Van Meter TE; Hwang EI; Gajjar A; Chiou SH; Nakamura H; Toledano H; Fried I; Fults D; Wataya T; Fryer C; Eisenstat DD; Scheinemann K; Fleming AJ; Johnston DL; Michaud J; Zelcer S; Hammond R; Afzal S; Ramsay DA; Sirachainan N; Hongeng S; Larbcharoensub N; Grundy RG; Lulla RR; Fangusaro JR; Druker H; Bartels U; Grant R; Malkin D; McGlade CJ; Nicolaides T; Tihan T; Phillips J; Majewski J; Montpetit A; Bourque G; Bader GD; Reddy AT; Gillespie GY; Warmuth-Metz M; Rutkowski S; Tabori U; Lupien M; Brudno M; Schüller U; Pietsch T; Judkins AR; Hawkins CE; Bouffet E; Kim SK; Dirks PB; Taylor MD; Erdreich-Epstein A; Arrowsmith CH; De Carvalho DD; Rutka JT; Jabado N; Huang A
Cancer Cell; 2016 Dec; 30(6):891-908. PubMed ID: 27960086
[TBL] [Abstract][Full Text] [Related]
23. Pituitary atypical teratoid rhabdoid tumor in a patient with prolactinoma: A unique description.
Barresi V; Lionti S; Raso A; Esposito F; Cannavò S; Angileri FF
Neuropathology; 2018 Jun; 38(3):260-267. PubMed ID: 29110337
[TBL] [Abstract][Full Text] [Related]
24. SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors.
Jeibmann A; Schulz J; Eikmeier K; Johann PD; Thiel K; Tegeder I; Ambrée O; Frühwald MC; Pfister SM; Kool M; Paulus W; Hasselblatt M
J Neurooncol; 2017 Feb; 131(3):477-484. PubMed ID: 28108836
[TBL] [Abstract][Full Text] [Related]
25. Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012.
Slavc I; Chocholous M; Leiss U; Haberler C; Peyrl A; Azizi AA; Dieckmann K; Woehrer A; Peters C; Widhalm G; Dorfer C; Czech T
Cancer Med; 2014 Feb; 3(1):91-100. PubMed ID: 24402832
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells.
Alimova I; Birks DK; Harris PS; Knipstein JA; Venkataraman S; Marquez VE; Foreman NK; Vibhakar R
Neuro Oncol; 2013 Feb; 15(2):149-60. PubMed ID: 23190500
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging spectroscopy in pediatric atypical teratoid rhabdoid tumors of the brain.
Bruggers CS; Moore K
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e341-5. PubMed ID: 24072251
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance imaging surrogates of molecular subgroups in atypical teratoid/rhabdoid tumor.
Nowak J; Nemes K; Hohm A; Vandergrift LA; Hasselblatt M; Johann PD; Kool M; Frühwald MC; Warmuth-Metz M
Neuro Oncol; 2018 Nov; 20(12):1672-1679. PubMed ID: 30010851
[TBL] [Abstract][Full Text] [Related]
29. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.
Tekautz TM; Fuller CE; Blaney S; Fouladi M; Broniscer A; Merchant TE; Krasin M; Dalton J; Hale G; Kun LE; Wallace D; Gilbertson RJ; Gajjar A
J Clin Oncol; 2005 Mar; 23(7):1491-9. PubMed ID: 15735125
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer Database.
Fischer-Valuck BW; Chen I; Srivastava AJ; Floberg JM; Rao YJ; King AA; Shinohara ET; Perkins SM
Cancer; 2017 Feb; 123(4):682-687. PubMed ID: 27861763
[TBL] [Abstract][Full Text] [Related]
31. Atypical Teratoid/Rhabdoid Sellar Tumor in an Adult with a Familial History of a Germline SMARCB1 Mutation: Case Report and Review of the Literature.
Voisin MR; Ovenden C; Tsang DS; Gupta AA; Huang A; Gao AF; Diamandis P; Almeida JP; Gentili F
World Neurosurg; 2019 Jul; 127():336-345. PubMed ID: 31004861
[TBL] [Abstract][Full Text] [Related]
32. Targeting the TP53/MDM2 axis enhances radiation sensitivity in atypical teratoid rhabdoid tumors.
Alimova I; Wang D; Danis E; Pierce A; Donson A; Serkova N; Madhavan K; Lakshmanachetty S; Balakrishnan I; Foreman NK; Mitra S; Venkataraman S; Vibhakar R
Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35179215
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets.
Sredni ST; Bonaldo Mde F; Costa FF; Huang CC; Hamm CA; Rajaram V; Tomita T; Goldman S; Bischof JM; Soares MB
Childs Nerv Syst; 2010 Mar; 26(3):279-83. PubMed ID: 20012062
[TBL] [Abstract][Full Text] [Related]
34. Wnt pathway in atypical teratoid rhabdoid tumors.
Chakravadhanula M; Hampton CN; Chodavadia P; Ozols V; Zhou L; Catchpoole D; Xu J; Erdreich-Epstein A; Bhardwaj RD
Neuro Oncol; 2015 Apr; 17(4):526-35. PubMed ID: 25246426
[TBL] [Abstract][Full Text] [Related]
35. SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors.
Xue Y; Zhu X; Meehan B; Venneti S; Martinez D; Morin G; Maïga RI; Chen H; Papadakis AI; Johnson RM; O'Sullivan MJ; Erdreich-Epstein A; Gotlieb WH; Park M; Judkins AR; Pelletier J; Foulkes WD; Rak J; Huang S
J Pathol; 2020 Sep; 252(1):77-87. PubMed ID: 32558936
[TBL] [Abstract][Full Text] [Related]
36. Atypical teratoid rhabdoid tumors (ATRTs): the British Columbia's Children's Hospital's experience, 1986-2006.
Fleming AJ; Hukin J; Rassekh R; Fryer C; Kim J; Stemmer-Rachamimov A; Birks DK; Huang A; Yip S; Dunham C
Brain Pathol; 2012 Sep; 22(5):625-35. PubMed ID: 22188464
[TBL] [Abstract][Full Text] [Related]
37. Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor.
Fahiminiya S; Witkowski L; Nadaf J; Carrot-Zhang J; Goudie C; Hasselblatt M; Johann P; Kool M; Lee RS; Gayden T; Roberts CW; Biegel JA; Jabado N; Majewski J; Foulkes WD
Oncotarget; 2016 Jan; 7(2):1732-40. PubMed ID: 26646792
[TBL] [Abstract][Full Text] [Related]
38. Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells.
Venkataraman S; Alimova I; Tello T; Harris PS; Knipstein JA; Donson AM; Foreman NK; Liu AK; Vibhakar R
J Neurooncol; 2012 May; 107(3):517-26. PubMed ID: 22246202
[TBL] [Abstract][Full Text] [Related]
39. Drug screening with a novel tumor-derived cell line identified alternative therapeutic options for patients with atypical teratoid/rhabdoid tumor.
Nakano Y; Takadera M; Miyazaki M; Qiao Z; Nakajima K; Noguchi R; Oyama R; Kimura Y; Okuhiro Y; Yamasaki K; Kunihiro N; Fukushima H; Inoue T; Hara J; Ozawa T; Kondo T; Ichimura K
Hum Cell; 2021 Jan; 34(1):271-278. PubMed ID: 32997328
[TBL] [Abstract][Full Text] [Related]
40. Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors.
Hoffman LM; Richardson EA; Ho B; Margol A; Reddy A; Lafay-Cousin L; Chi S; Slavc I; Judkins A; Hasselblatt M; Bourdeaut F; Frühwald MC; Vibhakar R; Bouffet E; Huang A
Neuro Oncol; 2020 Jul; 22(7):944-954. PubMed ID: 32129445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
